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Dimerization of FGFR3 in Living Cells
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Kalina Hristova.
Johns Hopkins University, Baltimore, MD, USA.
Receptor Tyrosine Kinases (RTKs) transduce biochemical signals via
lateral dimerization in the membrane plane. Yet, our knowledge about the
thermodynamics of RTK dimerization in cellular membranes is very limited.
We are working to develop a FRET-based methodology to measure the
dimerization free energies for RTKs in cells. We measure FRET with high
spectral resolution, and we calculate the FRET efficiencies with high preci-
sion for each pixel of the cellular membrane. Here we present data for Fibro-
blast Growth Factor Receptor 3, an RTK that is critical for skeletal
development. Since this receptor is activated by the ligand fgf1, we compare
the FRET efficiencies with and without ligand. Consistent with the expecta-
tion that fgf1 stabilizes the FGFR3 dimer, we see an increase in the FRET
signal.
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U24 is a type II tail-anchored putative membrane protein unique to the Rose-
olovirus family, including HHV-6 and HHV-7. It contains an N-terminal
proline-rich region and is believed to function by disrupting the signalling
pathway in order to ensure the virus’ survival. HHV-6A is a neurovirulent virus
as it is often found in multiple sclerosis (MS) patients. It has also been shown to
directly induce demyelination, a typical MS symptom, in naı¨ve adult marmo-
sets1. U24 from HHV-6A shares a seven residue identity with myelin basic pro-
tein (MBP), a protein responsible for the compaction of the myelin sheath in the
CNS2. U24 from HHV-7, on the other hand, does not share this sequence iden-
tity with MBP, but this virus has also been implicated in MS, though
indirectly3.
In order to elucidate the exact role of U24 in MS, we have investigated the
interaction of this protein with other partners such as the SH3 domain from
Fyn tyrosine kinase and WW domain proteins. GST pull-downs, NMR titra-
tion data and molecular dynamics simulations will be presented. The differ-
ences in binding observed for U24 from HHV-6A and -7 will shed light
into the hypothesis that U24 may function by mimicking MBP, as it has
been previously shown that U24 and MBP can be phosphorylated in a similar
manner4.
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Protonated aminosulfonates (AS), notably taurine, directly and reversibly
inhibit homomeric and heteromeric channels that contain Cx26, a widely
distributed connexin, but not homomeric Cx32 channels. Our previous bio-
physical studies identify the carboxyl-terminal domain of Cx26 (Cx26CT)as a key component of the channel modulation, suggesting a mechanism by
which AS disrupts a pH-dependent association between the CT and cyto-
plasmic loop of Cx26 (Cx26CL), leading to occlusion of the pore [1,2]. Using
recombinantly expressed Cx26CL and a Cx26CT peptide, NMR showed that
taurine binds to the CL and not the CT, and that the CT and CL directly
interact [3]. Our next goal to further characterize this mechanism is to identify
the Cx26CL residues that directly interact with the Cx26CT and taurine. The
Cx26CL construct used in the prior study (residues 98-139) contained a num-
ber of hydrophobic residues on the C-terminus, likely membrane associated,
which decreased solubility below levels needed for detailed structural studies.
Therefore, we created a shorter Cx26CL construct (residues 98-134) and were
able to achieve millimolar soluble concentrations. Using this construct, we
demonstrated by NMR a substantial interaction between the Cx26CT and
the Cx26CL, which was blocked by taurine. Ongoing studies will determine
(i) the binding affinities between the molecular partners, (ii) identify the
Cx26CL residues involved in these regulatory interactions, and (iii) explore
the potential effects of the Cx32CL and CT domains on these interactions,
as may occur in Cx26-Cx32 heteromeric channels. Support: GM072631 &
GM101950.
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Core histone is composed of two H2A-H2B dimers and H3-H4 tetramers.
Each histone have tail domain, which regulates dynamic structure of chro-
matin and transcription through posttranslational modifications. Histone
acetylation-deacetylation is one of such epigenetic regulations of gene
expression in eukaryotes. Histone deacetylase (HDAC) catalyze deacetyla-
tion of lysine residues in N-terminal domain of core histones and regulates
gene transcription and expression. Inhibition of HDAC induces transcrip-
tionally active chromatin, causing arrest of growth, differentiation and
apoptosis. HDAC inhibitors are thought to be effective for neurodegenera-
tive disorders, cardiac hypertrophy, inflammation and cancer. Using inhibi-
tor composed of photochromic molecules, can be changed its property
reversibly according to the wavelength of irradiated light, reversible site-
directed regulation is thought to be achieved without displacement of solu-
tion or chemical modification to HDAC itself. In this study, we designed
and synthesized three kinds of novel photochromic HDAC inhibitor,
N-(2-hydroxy-5-phenylphenyl)-4-[(E)-2-phenyldiazen-1-yl]benzamide, N-
phenyl-4-[(E)-2-phenyldiazen-1-yl]benzamide, and N-[4-({4-[(E)-2-phenyl-
diazen-1-yl]phenyl}formamido) butyl]-2-sulfanylacetamide composed of
azobenzene moiety which may bind specifically to surface region, and ben-
zamide or thiol group, which may bind to metal ion on active center ,
respectively. The design of the photochromic inhibitor was based on known
HDAC inhibitor, which is known to affect HDAC class 1 selectively. Azo-
benzene moiety is placed in hydrophobic interacting region of inhibitor,
therefore, it is expected that the light-induced structural change affects its
affinity for HDACs. The synthesized photochromic HDAC inhibitor showed
light-induced isomerization, derived from azobenzene moiety. Both of the
cis and trans isomers of the inhibitor showed inhibitory effect of human
whole HDAC activity. The trans-isomer of photochromic HDAC inhibitors
showed higher inhibitory effect to HDAC in hela nuclear extract than cis
isomer.
